Node Context · New Drugs & Biosimilars
KOSDAQ · 298380

ABL Bio Inc.

New Drugs & Biosimilars · Individual stock relative-strength trackerLive reactions on X
Price
₩43,400
Intraday · 11:31 KST
1D Change
-0.23%
Intraday · 11:31 KST
Market Cap
₩2.4T
Intraday · 11:31 KST
StockRank
43.7

ABL Bio Inc. (298380) is listed on KOSDAQ. StockRank shown here is based on New Drugs & Biosimilars. The same stock can score differently under a different node. On weekly moving averages it is in bearish (inverted) order, for 12 weeks since the week of 26-07-31. The sections below cover its price history, earnings and cash flow, foreign ownership, short-selling balance, and National Pension Service holdings.

Node correlation is strong (0.7 or above), while ETF weight is weak (0.3 or below).

RS Norm?
0.43
Momentum Norm?
0.48
Volume Surge?
0.53
Node Corr?
0.89
ETF Weight?
0.06
Trading Value
₩17.4B
FCF Yield?
-1.93%
Revenue Growth TTM?
-63.89%
Recent Signal Tapelatest 8 sessions

StockRank rose 3.6 points over the last 8 sessions.

DateRankRSMOMVOLCORR
26-10-1343.70.430.480.530.89
26-10-1243.70.430.500.510.88
26-10-0848.00.510.530.600.88
26-10-0746.50.520.510.550.88
26-10-0647.10.540.470.570.88
26-10-0245.00.510.440.570.87
26-10-0145.40.530.410.630.86
26-09-3040.10.420.380.590.72
NPS Stake ChangesLast 3
As ofSourceShares HeldStake %Change
26-04-01Major holder2,224,0874.02%↓
26-02-04Quarterly filing2,250,6964.02%↓
25-01-06Major holder2,704,2425.02%→
Data source: National Pension Service (NPS) Fund Disclosure (quarterly) + DART e-disclosure (real-time)
ETF Holdings PerformanceHolding weight 5%+ (top 50 sector ETFs + top 50 by trading value, 100 total)

The stock's 20-session return of −37.0% is 21.3pp behind the average of the 5 ETFs that hold it (−15.7%).

ETFCode20D ReturnWeight
HANARO Bio Korea Active498050-14.42%10.20%
KoAct Bio Healthcare Active462900-15.38%8.41%
TIME K-Bio Active463050-15.42%6.95%
ACE K-Bio KOSDAQ Active0221Z0-16.05%6.19%
MIGHTY New Drug Focus Bio Active0229F0-17.15%5.42%